So, Lorlatinib is this really cool, third-generation drug that’s all about fighting this tough cancer called ALK-positive metastatic non-small cell lung cancer, specifically when it’s been tough to treat with other ALK inhibitors before. You can get Lorlatinib in two doses: 25 mg and 100 mg, and they’re both in these film-coated tablet things. The usual dose is 100 mg, taken once a day, and you can take it with or without food, whichever works best for you.
Each bottle comes with 30 tablets. Lorlatinib works by zeroing in on these ALK and ROS1 kinases to stop tumor growth in its tracks.
